---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-009060"
form_type: "8-K"
ticker: "DWTX"
cik: "0001818844"
company_name: "Dogwood Therapeutics, Inc."
filed_at: "2025-07-02T23:59:59+00:00"
generated_at: "2026-05-18T09:40:36.106644+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Dogwood Therapeutics increases CFO Angela Walsh's base salary to $321,903

## Summary
- Board approved CFO salary increase from $279,916 to $321,903 per year.
- Increase effective July 1, 2025, based on peer company compensation review.
- Ms. Walsh remains CFO, Corporate Secretary and Treasurer.

## SEC filing metadata
- accession: 0001558370-25-009060
- form_type: 8-K
- ticker: DWTX
- cik: 0001818844
- company_name: Dogwood Therapeutics, Inc.
- filed_at: 2025-07-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818844/000155837025009060/0001558370-25-009060-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818844/000155837025009060/dwtx-20250627x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-009060
- JSON: https://secwatch.observer/filing/0001558370-25-009060.json
- Plain text: https://secwatch.observer/filing/0001558370-25-009060.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.